<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2784">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02626377</url>
  </required_header>
  <id_info>
    <org_study_id>P/2014/231</org_study_id>
    <nct_id>NCT02626377</nct_id>
  </id_info>
  <brief_title>Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté</brief_title>
  <acronym>ICE</acronym>
  <official_title>Multicenter Prospective Cohort of Informal Caregivers in Burgundy-Franche-Comté. ICE Cohort (Informal Caregivers of Elderly)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Methodological and quality of life unit in oncology (CHRU de Besançon)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Franche-Comté</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Burgundy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pôle de Gérontologie Interrégional Bourgogne et Franche-Comté</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CARSAT Bourgogne et Franche-Comté</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CCAS of Dijon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CCAS of Besançon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CCAS of Montbéliard</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Burgundy Regional Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Franche-Comté Regional Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Municipality of Besançon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Municipality of Dijon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Council of the Doubs</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Council of the Territoire de Belfort</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Collectif Inter Associatif Sur la Sante Bourgogne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Union Régionale Interfédérale des Œuvres et Organismes Privés Sanitaires Bourgogne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Association Gérontopôle Pierre Pfitzenmeyer</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pôle de compétitivité Vitagora Goût-Nutrition-Santé</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Old Age Insurance Fund for Employees (CNAVTS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sheerbrooke Gérontopôle</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>France Alzheimer</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut Régional de Vieillissement (IRV)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Roche Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ligue contre le cancer, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Quality of life and cancer clinical research platform</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Medical progress and modification of lifestyles have prolonged life expectancy, despite the&#xD;
      development of chronic diseases. The support and care are often provided by a network of&#xD;
      informal caregivers composed of family, friends, and neighbors. They became essential to help&#xD;
      maintening the elderly persons to live at home. It has been demonstrated that the importance&#xD;
      and the diversity of informal tasks may jeopardize their own physical, mental and social&#xD;
      well-being.&#xD;
&#xD;
      The aim of the Informal Carers of Elderly Cohort is to define, through a longitudinal study&#xD;
      of their life course, the profiles of caregivers of patients with a diagnosis of one of the&#xD;
      following diseases: cancer (breast, prostate, colon-rectum), neuro-degenerative diseases&#xD;
      (Parkinson's disease, Alzheimer's and similar diseases), neuro-vascular diseases&#xD;
      (Cerebrovascular Accident (CVA)), Age-related Macular Degeneration(AMD) and heart disease&#xD;
      (heart failure), aged ≥ 60 years old and living in Burgundy or Franche-Comte. By following&#xD;
      the different phases of the caregiving relationship from the announcement of the diagnosis,&#xD;
      it will be possible to assess the quality of life of caregivers and evaluate the&#xD;
      implementation of a pragmatic social action to help informal caregivers through a randomized&#xD;
      intervention trial nested in the cohort.&#xD;
&#xD;
      Thanks to an analytical and longitudinal definition of the profiles of informal caregivers,&#xD;
      this study could gather precise information on their life courses and their health trajectory&#xD;
      by identifying the consequences associated with the concept of their role of aid in care. In&#xD;
      addition, the randomized intervention trial will explore the efficacy, in terms of quality of&#xD;
      life, and efficiency of a social action to support the caregivers. These data will allow to&#xD;
      identify strategies that could be used to improve the existing sources of aid and to propose&#xD;
      new approaches to help caregivers. This study will provide the opportunity to identify the&#xD;
      most relevant means of support and to give an impulse for new healthcare policies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    inclusions problems&#xD;
  </why_stopped>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">May 2019</completion_date>
  <primary_completion_date type="Actual">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>(Interventional Study) Comparison of caregivers' HRQoL according to the allocated intervention by randomization based on summaries score the MOS SF36</measure>
    <time_frame>One year after randomization</time_frame>
    <description>The main objective of the randomized study is to compare the Health Related Quality of Life based on summaries score the MOS SF36 one year after randomization according to the allocated intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>(Observational study) Changes in HRQoL of patients' caregivers using the MOS SF36 questionnaire</measure>
    <time_frame>At 1, 3, 6, 9, 12, 15,18, 21, 24, 30, 36, 42, 48, 54 and 60 months post-randomization</time_frame>
    <description>The main objective of the observational study is to define the longitudinal profiles of patient's caregivers according to the evaluation of their HRQoL using the MOS SF36 questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>(Observational study) Changes in HRQoL of cancer patients' caregivers using the CarGoQoL questionnaire</measure>
    <time_frame>At 1, 3, 6, 9, 12, 18, 24, 30, 36, 42, 48,54 and 60 months post-randomization</time_frame>
    <description>the aim of the observational study is to define the longitudinal profiles of cancer patient's caregivers according to the evaluation of their HRQoL using the CarGoQoL questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>(Observational study) Changes in the coping strategies of patients' caregivers using the Borteyrou, Rascle and Truchot Questionnaire</measure>
    <time_frame>At 1, 6, 12, 24, 36, 48 and 60 months post-randomization</time_frame>
    <description>The aim of the observational study is to define the longitudinal profiles of patient's caregivers according to the evaluation of their coping strategies using the Borteyrou, Rascle and Truchot Questionnaire.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>(Observational study) Changes in feelings of anxiety and depression of patients' caregivers according to the HADs questionnaire</measure>
    <time_frame>At 1, 3, 6, 9, 12, 18, 24, 30, 36, 42, 48,54 and 60 months post-randomization</time_frame>
    <description>The aim of the observational study is to define the longitudinal profiles of patient's caregivers according to the evaluation of their anxiety and depression according to the HADs questionnaire.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>(Observational study) Changes in social support of patients' caregivers using the SSQ6 questionnaire</measure>
    <time_frame>At 1, 6, 12, 24, 36, 48 and 60 months post-randomization</time_frame>
    <description>The aim of the observational study is to define the longitudinal profiles of patient's caregivers according to the evaluation of their social support using the SSQ6 questionnaire.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>(Observational study) Changes in burden of patients' caregivers using the Zarit burden inventory</measure>
    <time_frame>At 1, 6, 12, 24, 36, 48 and 60 months post-randomization</time_frame>
    <description>The aim of the observational study is to define the longitudinal profiles of patient's caregivers according to the evaluation burden using the Zarit burden inventory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>(Interventional Study) Comparison of caregivers' HRQoL according to the intervention allocated by randomization based on summaries score the MOS SF36</measure>
    <time_frame>Two years after randomization</time_frame>
    <description>To compare the Health Related Quality of Life based on summaries score the MOS SF36 two years after randomization according to the allocated intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Interventional Study) Changes in HRQoL of patients' caregivers according to the allocated intervention using the MOS SF36 questionnaire</measure>
    <time_frame>At 1, 3, 6, 9, 12, 15,18, 21, 24, 30, 36, 42, 48, 54 and 60 months post-randomization</time_frame>
    <description>To compare longitudinally all dimensions of HRQoL using the MOS SF36 questionnaire according to the allocated intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Interventional Study) Changes in HRQoL of cancer patients' caregivers according to the allocated intervention using the CarGoQol questionnaire</measure>
    <time_frame>At 1, 3, 6, 9, 12, 18, 24, 30, 36, 42, 48,54 and 60 months post-randomization</time_frame>
    <description>To compare longitudinally the HRQoL of cancer patients' caregivers, according to the allocated intervention, using the CarGoQol questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Interventionnal Study) Changes in the coping strategies of patients' caregivers according to the allocated intervention using the Borteyrou, Rascle and Truchot Questionnaire</measure>
    <time_frame>At 1, 6, 12, 24, 36, 48 and 60 months post-randomization</time_frame>
    <description>To compare longitudinally the coping strategies of patients' caregivers, according to the allocated intervention, using the Borteyrou, Rascle and Truchot Questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Interventional Study) Changes in feelings of anxiety and depression of patients' caregivers according to the allocated intervention using the HADs Questionnaire</measure>
    <time_frame>At 1, 3, 6, 9, 12, 18, 24, 30, 36, 42, 48,54 and 60 months post-randomization</time_frame>
    <description>To compare longitudinally the feelings of anxiety and depression of patients' caregivers, according to the allocated intervention, using the HADs Questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Interventional Study) Changes in social supports of patients' caregivers according to the allocated intervention using the SSQ6 questionnaire</measure>
    <time_frame>At 1, 6, 12, 24, 36, 48 and 60 months post-randomization</time_frame>
    <description>To compare longitudinally the social support of patients' caregivers, according to the allocated intervention, using the SSQ6 questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Interventional Study) Changes in burden of patients' caregivers according to the allocated intervention using the Zarit burden inventory</measure>
    <time_frame>At 1, 6, 12, 24, 36, 48 and 60 months post-randomization</time_frame>
    <description>To compare longitudinally the burden of patients' caregivers, according to the allocated intervention, using the Zarit burden inventory.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Interventional study) Efficiency of the intervention of a social worker for caregivers using a cost-utility analysis</measure>
    <time_frame>At 1, 3, 6,9,12,15,18 and 24 months post-randomization</time_frame>
    <description>The efficiency of the intervention of a social worker for caregivers will be assessed using a cost-utility analysis, aiming at comparing in terms of costs and utility the intervention versus the absence of intervention of a social worker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Observational study) Changes in the caregivers/patients' relationship using a qualitative approach (semi-structure interview)</measure>
    <time_frame>At 1,6,12,18,24,30,36,42,48,54 and 60 months post randomization</time_frame>
    <description>to evaluate the caregivers/patients' relationship and the changes of the relationship using a qualitative approach (semi-structure interview), to describe the specificity of the care and of the help from people carrying diseases with behavioral disorders (Alzheimer-type dementia in particular)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Observational study) Changes in the role of caregiver due to a situation generating a rupture (entry into an institution or death, disease remission) using a qualitative approach (semi-structure interview)</measure>
    <time_frame>At 1,6,12,18,24,30,36,42,48,54 and 60 months post randomization</time_frame>
    <description>to study the situations generating a rupture in their role of caregiver (entry into an institution or death, disease remission) using a qualitative approach (semi-structure interview)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">186</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Colorectal Cancer</condition>
  <condition>Prostate Cancer</condition>
  <condition>Alzheimer Disease</condition>
  <condition>Age-related Macular Degeneration</condition>
  <condition>Parkinson Disease</condition>
  <condition>Cardiac Disease</condition>
  <condition>Ischemic Stroke</condition>
  <condition>Hemorrhagic Stroke</condition>
  <arm_group>
    <arm_group_label>Interventional arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>'Support provided by social worker'</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-interventional arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>'Information booklet receipt'</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Support provided by social worker</intervention_name>
    <description>Caregivers randomized in intervention arm will receive an information booklet (which informs about existing structures and actions) and will receive support provided by a social worker schedule every 6 months during two years. The support duration will be one hour and will be defined as two parts: administration of the LASA questionnaire, and a standardized semi directive interview to assess needs.</description>
    <arm_group_label>Interventional arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Information booklet receipt</intervention_name>
    <description>Caregivers will only receive an information booklet (which informs about existing structures and actions)</description>
    <arm_group_label>Interventional arm</arm_group_label>
    <arm_group_label>Non-interventional arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patient :&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  To be able to identify a principal caregiver via a specific questionnaire (if the&#xD;
             patient is unable to identify himself his caregiver due to the disease, a&#xD;
             self-designation form as a principal caregiver will be allow and propose)&#xD;
&#xD;
          -  to accept to complete the questionnaire to designate the principal caregiver;&#xD;
&#xD;
          -  To live in either Burgundy-Franche-Comte county;&#xD;
&#xD;
          -  have been recently diagnosed at hospital or in private-sector for the following&#xD;
             diseases: Local or metastatic cancer diagnosed less than 6 month (breast&#xD;
             cancer-hormone sensitive- in first line chemotherapy treatment, hormone-sensitive&#xD;
             prostate cancer or in metastatic recurrence after 3 years of remission, considered as&#xD;
             a new case, colorectal cancer in first line chemotherapy treatment), a&#xD;
             neuro-degenerative disease (Parkinson disease diagnosed less than 7 years, Alzheimer&#xD;
             disease and similar diseases diagnosed less than 12 months and /or with a Mini Mental&#xD;
             State Examination (MMSE)&lt;24 and &gt;10 (performed less than 3 mois)), Age-related Macular&#xD;
             Degeneration,( geographic atrophy or neovascular, diagnosed less than 12 month with an&#xD;
             acuity range between 2 and 6/10e, be at least 65 years old and have received less than&#xD;
             3 sessions of intravitreal injections (IVT)), cardiac disease (heart failure diagnosed&#xD;
             less than 3 months), neuro-vascular disease (ischemic or hemorrhagic stroke with&#xD;
             clinical evidence of post stroke lesions upper than 24 hours, diagnosed less than 6&#xD;
             months and with a Rankin's score inferior or equal to 2).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previously diagnosed with another targeted disease and/or living in retirement home&#xD;
             could not be included&#xD;
&#xD;
        Caregiver&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  to be a member of the patient's social environment (family, friend and neighbor);&#xD;
&#xD;
          -  to be identify by the patient as the &quot;principal caregiver&quot; based on the designation&#xD;
             questionnaire or to have complete the self-designation form as a principal caregiver;&#xD;
&#xD;
          -  ≥ 18 years old;&#xD;
&#xD;
          -  not be an employee of a healthcare organization;&#xD;
&#xD;
          -  living in Burgundy-Franche-Comte;&#xD;
&#xD;
          -  to be able to complete questionnaires,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - to be under guardianship, curatorship or under the protection of justice&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Virginie NERICH, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pôle Pharmaceutique CHU de Besançon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2022</verification_date>
  <study_first_submitted>December 1, 2015</study_first_submitted>
  <study_first_submitted_qc>December 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2015</study_first_posted>
  <last_update_submitted>July 19, 2022</last_update_submitted>
  <last_update_submitted_qc>July 19, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Informal caregivers</keyword>
  <keyword>Elderly</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Cost effectiveness</keyword>
  <keyword>Cohort study</keyword>
  <keyword>Randomized study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Hemorrhagic Stroke</mesh_term>
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

